Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold C Standiford

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Critical Care Medicine|July 20, 2011
Empiric antimicrobial therapy for Gram-negative sepsis: back to the futureSurbhi Leekha, Harold C Standiford
Infection Control and Hospital Epidemiology|March 16, 2012
Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year programHarold C Standiford, Shannon Chan, Megan Tripoli, et al.
Infection Control and Hospital Epidemiology|July 16, 2014
Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical settingKerri A Thom, Harold C Standiford, J Kristie Johnson, et al.
Infection Control and Hospital Epidemiology|April 28, 2004
Preliminary assessment of an automated surveillance system for infection controlMarc-Oliver Wright, Eli N Perencevich, Christopher Novak, et al.
Journal of the American Medical Informatics Association : JAMIA|April 20, 2006
Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trialJessina C McGregor, Elizabeth Weekes, Graeme N Forrest, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studiesEthan Rubinstein, Raul Isturiz, Harold C Standiford, et al.
Infection Control and Hospital Epidemiology|March 5, 2004
Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unitMarc-Oliver Wright, Joan N Hebden, Anthony D Harris, et al.
Emerging Infectious Diseases|October 24, 2007
Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admissionAnthony D Harris, Jessina C McGregor, Judith A Johnson, et al.
American Journal of Infection Control|September 13, 2008
Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facilityJon P Furuno, Joan N Hebden, Harold C Standiford, et al.
Infection Control and Hospital Epidemiology|May 24, 2007
Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureusJon P Furuno, Anthony D Harris, Marc-Oliver Wright, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Critical Care Medicine|July 20, 2011
Empiric antimicrobial therapy for Gram-negative sepsis: back to the futureSurbhi Leekha, Harold C Standiford
Infection Control and Hospital Epidemiology|March 16, 2012
Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year programHarold C Standiford, Shannon Chan, Megan Tripoli, et al.
Infection Control and Hospital Epidemiology|July 16, 2014
Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical settingKerri A Thom, Harold C Standiford, J Kristie Johnson, et al.
Infection Control and Hospital Epidemiology|April 28, 2004
Preliminary assessment of an automated surveillance system for infection controlMarc-Oliver Wright, Eli N Perencevich, Christopher Novak, et al.
Journal of the American Medical Informatics Association : JAMIA|April 20, 2006
Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trialJessina C McGregor, Elizabeth Weekes, Graeme N Forrest, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studiesEthan Rubinstein, Raul Isturiz, Harold C Standiford, et al.
Infection Control and Hospital Epidemiology|March 5, 2004
Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unitMarc-Oliver Wright, Joan N Hebden, Anthony D Harris, et al.
Emerging Infectious Diseases|October 24, 2007
Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admissionAnthony D Harris, Jessina C McGregor, Judith A Johnson, et al.
American Journal of Infection Control|September 13, 2008
Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facilityJon P Furuno, Joan N Hebden, Harold C Standiford, et al.
Infection Control and Hospital Epidemiology|May 24, 2007
Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureusJon P Furuno, Anthony D Harris, Marc-Oliver Wright, et al.
Pageof 2